Shapes, Inc
This platform’s AI companions raise some major red flags.
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Similasan Eye Relief products
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Settled
(Final approval granted)
https://www.homeopathiceyedropsettlement.com/home
This platform’s AI companions raise some major red flags.
“Free” offer could prove costly.
Company’s animal welfare claims – and brand name – face increasing scrutiny.
Consumers balk at hidden junk fees.
TINA.org uncovers the limits of this carrier’s “unlimited” data plans.